Post-marketing safety surveillance of tarlatamab: a real-world pharmacovigilance study based on the FAERS database.

Saved in:
Bibliographic Details
Title: Post-marketing safety surveillance of tarlatamab: a real-world pharmacovigilance study based on the FAERS database.
Authors: Jin X; Department of Oncology, Affiliated Hospital of Qinghai University, Graduate School of Qinghai University, 29 Tongren Road, Chengxi District, Xining City, Qinghai, China., Zhao W; Department of Oncology, Affiliated Hospital of Qinghai University, Graduate School of Qinghai University, 29 Tongren Road, Chengxi District, Xining City, Qinghai, China. zhaoweixing213@126.com., Li Y; Department of Oncology, Affiliated Hospital of Qinghai University, Graduate School of Qinghai University, 29 Tongren Road, Chengxi District, Xining City, Qinghai, China., Peng H; Department of Oncology, Affiliated Hospital of Qinghai University, Graduate School of Qinghai University, 29 Tongren Road, Chengxi District, Xining City, Qinghai, China.
Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2026 Apr; Vol. 399 (7), pp. 10097-10110. Date of Electronic Publication: 2026 Jan 29.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-1912
DOI:10.1007/s00210-026-05028-y